Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 12
Submit an article Journal homepage
2,250
Views
92
CrossRef citations to date
0
Altmetric
Review

Trial Watch

Peptide vaccines in cancer therapy

Fernando Aranda Gustave Roussy; Villejuif, France; INSERM, U848; Villejuif, France; Université Paris-Sud/Paris XI; Le Kremlin-Bicêtre, France; Equipe 11 labellisée par la Lique Nationale contre le Cancer; Centre de Recherche des Cordeliers; Paris, France
,
Erika Vacchelli Gustave Roussy; Villejuif, France; INSERM, U848; Villejuif, France; Université Paris-Sud/Paris XI; Le Kremlin-Bicêtre, France; Equipe 11 labellisée par la Lique Nationale contre le Cancer; Centre de Recherche des Cordeliers; Paris, France
,
Alexander Eggermont Gustave Roussy; Villejuif, France
,
Jérôme Galon Université Paris Descartes/Paris V, Sorbonne Paris Cité; Paris, France; Université Pierre et Marie Curie/Paris VI; Paris, France; INSERM, U872; Paris, France; Equipe 15, Centre de Recherche des Cordeliers; Paris, France
,
Catherine Sautès-Fridman Université Pierre et Marie Curie/Paris VI; Paris, France; INSERM, U872; Paris, France; Equipe 13, Centre de Recherche des Cordeliers; Paris, France
,
Eric Tartour Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; INSERM, U970; Paris, France
,
Laurence Zitvogel Gustave Roussy; Villejuif, France; INSERM, U1015; CICBT507; Villejuif, France
,
Guido Kroemer Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; INSERM, U848; Villejuif, France; Equipe 11 labellisée par la Lique Nationale contre le Cancer; Centre de Recherche des Cordeliers; Paris, France; Université Paris Descartes/Paris V, Sorbonne Paris Cité; Paris, France; Metabolomics and Cell Biology Platforms; Gustave Roussy; Villejuif, FranceCorrespondence[email protected] [email protected]
&
Lorenzo Galluzzi Gustave Roussy; Villejuif, France; Equipe 11 labellisée par la Lique Nationale contre le Cancer; Centre de Recherche des Cordeliers; Paris, France; Université Paris Descartes/Paris V, Sorbonne Paris Cité; Paris, FranceCorrespondence[email protected] [email protected]
 show all
Article: e26621 | Received 25 Sep 2013, Accepted 26 Sep 2013, Published online: 04 Nov 2013

Citations (92)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (32)

Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Maximos Frountzas, Konstantinos Apostolou & Dimitrios Schizas. (2022) Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights. Cancer Management and Research 14, pages 1043-1061.
Read now
Adriana Petrazzuolo, M. Chiara Maiuri, Laurence Zitvogel, Guido Kroemer & Oliver Kepp. (2022) Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy. OncoImmunology 11:1.
Read now
Mi Tang, Jiang-Hui Cai, Hao-Yang Diao, Wen-Mei Guo, Xiao Yang & ShaSha Xing. (2022) The progress of peptide vaccine clinical trials in gynecologic oncology. Human Vaccines & Immunotherapeutics 18:5.
Read now
Pauline Maby, Gabriela Bindea, Bernhard Mlecnik & Jérôme Galon. (2021) License to kill: microsatellite instability and immune contexture. OncoImmunology 10:1.
Read now
Florence Marliot, Franck Pagès & Jérôme Galon. (2020) Usefulness and robustness of Immunoscore for personalized management of cancer patients. OncoImmunology 9:1.
Read now
Paolo A. Ascierto, Francesco M. Marincola, Bernard A. Fox & Jérôme Galon. (2020) No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study. OncoImmunology 9:1.
Read now
Bernhard Mlecnik, Gabriela Bindea, Marc Van den Eynde & Jérôme Galon. (2020) Metastasis immune-based scores predict patient survival. OncoImmunology 9:1.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
Cristian Capasso, Mari Hirvinen, Mariangela Garofalo, Dmitrii Romaniuk, Lukasz Kuryk, Teea Sarvela, Andrea Vitale, Maxim Antopolsky, Aniket Magarkar, Tapani Viitala, Teemu Suutari, Alex Bunker, Marjo Yliperttula, Arto Urtti & Vincenzo Cerullo. (2016) Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma. OncoImmunology 5:4.
Read now
Kristina Iribarren, Norma Bloy, Aitziber Buqué, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Špíšek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. OncoImmunology 5:3.
Read now
Erika Vacchelli, Fernando Aranda, Norma Bloy, Aitziber Buqué, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Immunostimulation with cytokines in cancer therapy. OncoImmunology 5:2.
Read now
Jorge Alberto Salazar-González, Omar González-Ortega & Sergio Rosales-Mendoza. (2015) Gold nanoparticles and vaccine development. Expert Review of Vaccines 14:9, pages 1197-1211.
Read now
Guido Kroemer & Lorenzo Galluzzi. (2015) Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma—An exclamation sign with a question mark. OncoImmunology 4:7.
Read now
Norma Bloy, Aitziber Buqué, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology 4:5.
Read now
Yoshihiko Hirohashi, Toshihiko Torigoe, Tasuku Mariya, Vitaly Kochin, Tsuyoshi Saito & Noriyuki Sato. (2015) HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancer. OncoImmunology 4:5.
Read now
François Bertucci, Pascal Finetti, Emilie Mamessier, Maria Abbondanza Pantaleo, Annalisa Astolfi, Jerzy Ostrowski & Daniel Birnbaum. (2015) PDL1 expression is an independent prognostic factor in localized GIST. OncoImmunology 4:5.
Read now
Florine Obrist, Gwenola Manic, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2015) Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology 2:2.
Read now
Jonathan Pol, Norma Bloy, Aitziber Buqué, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Peptide-based anticancer vaccines. OncoImmunology 4:4.
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Aurélien Marabelle, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology 4:4.
Read now
Erika Vacchelli, Jonathan Pol, Norma Bloy, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jérôme Galon, Aurélien Marabelle, Holbrook Kohrt, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. OncoImmunology 4:1.
Read now
Robert K Bright, Jennifer D Bright & Jennifer A Byrne. (2014) Overexpressed oncogenic tumor-self antigens. Human Vaccines & Immunotherapeutics 10:11, pages 3297-3305.
Read now
Lorenzo Galluzzi, Guido Kroemer & Alexander Eggermont. (2014) Novel immune checkpoint blocker approved for the treatment of advanced melanoma. OncoImmunology 3:11.
Read now
Norma Bloy, Jonathan Pol, Fernando Aranda, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fučíková, Jérôme Galon, Eric Tartour, Radek Spisek, Madhav V. Dhodapkar, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch: Dendritic cell-based anticancer therapy. OncoImmunology 3:11.
Read now
Norma Bloy, Jonathan Pol, Gwenola Manic, Ilio Vitale, Alexander Eggermont, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch: Radioimmunotherapy for oncological indications. OncoImmunology 3:9.
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Catherine Sautès-Fridman, Eric Tartour, Eugene P Kennedy, Michael Platten, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch: IDO inhibitors in cancer therapy. OncoImmunology 3:10.
Read now
Erika Vacchelli, Fernando Aranda, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch. OncoImmunology 3:6.
Read now
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Philippe Erbs, Jean-Marc Limacher, Xavier Preville, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch:. OncoImmunology 3:6.
Read now
Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Isabelle Cremer, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:5.
Read now
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:4.
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:2.
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:1.
Read now
Gwenola Manic, Florine Obrist, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2014) Chloroquine and hydroxychloroquine for cancer therapy. Molecular & Cellular Oncology 1:1.
Read now

Articles from other publishers (60)

Fatemeh Zahedipour, Khadijeh Jamialahmadi, Parvin Zamani & Mahmoud Reza Jaafari. (2023) Improving the efficacy of peptide vaccines in cancer immunotherapy. International Immunopharmacology 123, pages 110721.
Crossref
Joseph Willis, Robert A. Anders, Toshihiko Torigoe, Yoshihiko Hirohashi, Carlo Bifulco, Inti Zlobec, Bernhard Mlecnik, Sandra Demaria, Won-Tak Choi, Pavel Dundr, Fabiana Tatangelo, Annabella Di Mauro, Pamela Baldin, Gabriela Bindea, Florence Marliot, Nacilla Haicheur, Tessa Fredriksen, Amos Kirilovsky, Bénédicte Buttard, Angela Vasaturo, Lucie Lafontaine, Pauline Maby, Carine El Sissy, Assia Hijazi, Amine Majdi, Christine Lagorce, Anne Berger, Marc Van den Eynde, Franck Pagès, Alessandro Lugli & Jérôme Galon. (2023) Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore. Cancers 15:16, pages 4045.
Crossref
Christopher Cultrara, Christopher Uhl, Kenneth Kirby, Essam Abed Elrazaq, Amelia Zellander, David W Andrews, Charles B Scott, Lorenzo Galluzzi, Mark A Exley & Jenny Zilberberg. (2023) A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma. Journal for ImmunoTherapy of Cancer 11:8, pages e006880.
Crossref
Chen Shen, Mei Li, Yujuan Duan, Xin Jiang, Xiaoming Hou, Fulai Xue, Yinan Zhang & Yao Luo. (2023) HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Ying-Zhe Luo & Hong Zhu. (2023) Immunotherapy for advanced or recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 15:3, pages 405-424.
Crossref
Rabab A. Husseini, Tatsuya Fukuta, Mizune Ozono, Azza A. Hasan, Nagia A. El Megrab & Kentaro Kogure. (2023) The Effect of Iontophoretic-Delivered Polyplex Vaccine on Melanoma Regression. Biological and Pharmaceutical Bulletin 46:3, pages 494-504.
Crossref
Qiong Xu, Yan Zhou, Heng Zhang, Haipeng Li, Haoren Qin & Hui Wang. (2023) Bibliometric Analysis of Hotspots and Frontiers of Immunotherapy in Pancreatic Cancer. Healthcare 11:3, pages 304.
Crossref
Bernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, Florence Marliot, Carlo Bifulco, Jiun-Kae Jack Lee, Inti Zlobec, Tilman T. Rau, Martin D. Berger, Iris D. Nagtegaal, Elisa Vink-Börger, Arndt Hartmann, Carol I. Geppert, Julie Kolwelter, Susanne Merkel, Robert Grützmann, Marc Van den Eynde, Anne Jouret-Mourin, Alex Kartheuser, Daniel Léonard, Christophe Remue, Julia Wang, Prashant Bavi, Michael H. A. Roehrl, Pamela S. Ohashi, Linh T. Nguyen, SeongJun Han, Heather L. MacGregor, Sara Hafezi-Bakhtiari, Bradly G. Wouters, Giuseppe V. Masucci, Emilia K. Andersson, Eva Zavadova, Michal Vocka, Jan Spacek, Lubos Petruzelka, Bohuslav Konopasek, Pavel Dundr, Helena Skalova, Kristyna Nemejcova, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi, Fabio Grizzi, Tessa Fredriksen, Bénédicte Buttard, Lucie Lafontaine, Pauline Maby, Amine Majdi, Assia Hijazi, Carine El Sissy, Amos Kirilovsky, Anne Berger, Christine Lagorce, Christopher Paustian, Carmen Ballesteros-Merino, Jeroen Dijkstra, Carlijn van de Water, Shannon van Lent-van Vliet, Nikki Knijn, Ana-Maria Mușină, Dragos-Viorel Scripcariu, Boryana Popivanova, Mingli Xu, Tomonobu Fujita, Shoichi Hazama, Nobuaki Suzuki, Hiroaki Nagano, Kiyotaka Okuno, Toshihiko Torigoe, Noriyuki Sato, Tomohisa Furuhata, Ichiro Takemasa, Prabhu Patel, Hemangini H. Vora, Birva Shah, Jayendrakumar B. Patel, Kruti N. Rajvik, Shashank J. Pandya, Shilin N. Shukla, Yili Wang, Guanjun Zhang, Yutaka Kawakami, Francesco M. Marincola, Paolo A. Ascierto, Bernard A. Fox, Franck Pagès & Jérôme Galon. (2023) Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer. Cancers 15:2, pages 418.
Crossref
Zixu Liu, Linxuan Zhao, Yupeng Feng, Qingqing Wang, Nan Dong, Yu Zhang, Tian Yin, Haibing He, Xing Tang, Jingxin Gou & Li Yang. (2023) Dual-responsive PEG–lipid polyester nanoparticles for siRNA and vaccine delivery elicit anti-cancer immune responses by modulating tumor microenvironment. Biomaterials Science.
Crossref
Rahul Nandre, Vivek Verma, Pankaj Gaur, Veerupaxagouda Patil, Xingdong Yang, Zainab Ramlaoui, Nour Shobaki, Mads Hald Andersen, Ayako Wakatsuki Pedersen, Mai-Britt Zocca, Mikayel Mkrtichyan, Seema Gupta & Samir N. Khleif. (2022) IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status. Cancer Immunology Research 10:5, pages 571-580.
Crossref
Christo Kole, Nikolaos Charalampakis, Michail Vailas, Maria Tolia, Maria Sotiropoulou, Sergios Tsakatikas, Nikolaos-Iasonas Kouris, Marina Tsoli, Anna Koumarianou, Michalis V. Karamouzis & Dimitrios Schizas. (2021) Immunotherapy for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a 2021 update. Cancer Immunology, Immunotherapy 71:4, pages 761-768.
Crossref
Vikrant Rai & Sandeep Mukherjee. (2022) Targets of immunotherapy for hepatocellular carcinoma: An update. World Journal of Hepatology 14:1, pages 140-157.
Crossref
Lucy R. Hart, Charlotta G. Lebedenko, Saige M. Mitchell, Rachel E. Daso & Ipsita A. Banerjee. (2022) In Silico Studies of Tumor Targeted Peptide-Conjugated Natural Products for Targeting Over-Expressed Receptors in Breast Cancer Cells Using Molecular Docking, Molecular Dynamics and MMGBSA Calculations. Applied Sciences 12:1, pages 515.
Crossref
Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Nikolaos-Iasonas Kouris, George Papaxoinis, Michalis V Karamouzis, Anna Koumarianou & Dimitrios Schizas. (2022) Immunotherapy for gastric cancer: a 2021 update. Immunotherapy 14:1, pages 41-64.
Crossref
Diana C. DeLucia & John K. Lee. 2022. Cancer Immunotherapies. Cancer Immunotherapies 1 48 .
Praveen Bhoopathi, Padmanabhan Mannangatti, Luni Emdad, Swadesh K. Das & Paul B. Fisher. (2021) The quest to develop an effective therapy for neuroblastoma. Journal of Cellular Physiology 236:11, pages 7775-7791.
Crossref
Shihu Jiao, Quan Zou, Huannan Guo & Lei Shi. (2021) iTTCA-RF: a random forest predictor for tumor T cell antigens. Journal of Translational Medicine 19:1.
Crossref
Carlos A. Arbelaez, Juan Estrada, Melissa A. Gessner, Charles Glaus, Agnieszka B. Morales, Deanna Mohn, Hyewon Phee, J. Russell Lipford & James A. Johnston. (2020) A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses. npj Vaccines 5:1.
Crossref
Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Michail Vailas, Dimitrios Moris, Efthymios Gkotsis, Stylianos Kykalos, Michalis V. Karamouzis & Dimitrios Schizas. (2020) Immunotherapy for Hepatocellular Carcinoma: A 2021 Update. Cancers 12:10, pages 2859.
Crossref
Dimitrios Schizas, Nikolaos Charalampakis, Christo Kole, Panagiota Economopoulou, Evangelos Koustas, Efthymios Gkotsis, Dimitrios Ziogas, Amanda Psyrri & Michalis V. Karamouzis. (2020) Immunotherapy for pancreatic cancer: A 2020 update. Cancer Treatment Reviews 86, pages 102016.
Crossref
Fabio Marcelo Cerbán, Cinthia Carolina Stempin, Ximena Volpini, Eugenio Antonio Carrera Silva, Susana Gea & Claudia Cristina Motran. (2020) Signaling pathways that regulate Trypanosoma cruzi infection and immune response. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:5, pages 165707.
Crossref
Anne C. Conibear, Alanca Schmid, Meder Kamalov, Christian F.W. Becker & Claudia Bello. (2020) Recent Advances in Peptide-Based Approaches for Cancer Treatment. Current Medicinal Chemistry 27:8, pages 1174-1205.
Crossref
Dimitrios Schizas, Nikolaos Charalampakis, Christo Kole, Konstantinos S Mylonas, Ioannis Katsaros, Meina Zhao, Jaffer A Ajani, Amanda Psyrri, Michalis V Karamouzis & Theodore Liakakos. (2020) Immunotherapy for esophageal cancer: a 2019 update. Immunotherapy 12:3, pages 203-218.
Crossref
Jorge Félix Beltrán Lissabet, Lisandra Herrera Belén & Jorge G. Farias. (2019) TTAgP 1.0: A computational tool for the specific prediction of tumor T cell antigens. Computational Biology and Chemistry 83, pages 107103.
Crossref
Chao Wang, Steven N. Fiering & Nicole F. Steinmetz. (2019) Cowpea Mosaic Virus Promotes Anti‐Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model. Advanced Therapeutics 2:5, pages 1900003.
Crossref
Deena M. Maurer, Lisa H. Butterfield & Lazar Vujanovic. (2019) Melanoma vaccines: clinical status and immune endpoints. Melanoma Research 29:2, pages 109-118.
Crossref
Katja Sonntag, Hisayoshi Hashimoto, Matthias Eyrich, Moritz Menzel, Max Schubach, Dennis Döcker, Florian Battke, Carolina Courage, Helmut Lambertz, Rupert Handgretinger, Saskia Biskup & Karin Schilbach. (2018) Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report. Journal of Translational Medicine 16:1.
Crossref
Wataru Obara, Mitsugu Kanehira, Toyomasa Katagiri, Renpei Kato, Yoichiro Kato & Ryo Takata. (2018) Present status and future perspective of peptide‐based vaccine therapy for urological cancer. Cancer Science 109:3, pages 550-559.
Crossref
Kosaku Mimura, Leo Yamada, Daisuke Ujiie, Suguru Hayase, Takeshi Tada, Hiroyuki Hanayama, Aung Kyi Thar Min, Masahiko Shibata, Tomoyuki Momma, Zenichiro Saze, Shinji Ohki & Koji Kono. (2018) Immunotherapy for esophageal squamous cell carcinoma: a review. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 64:2, pages 46-53.
Crossref
Koji Kono, Kousaku Mimura, Reo Yamada, Daisuke Ujiie, Suguru Hayase, Takeshi Tada, Hiroyuki Hanayama, Aung Kyi Thar Min, Masahiko Shibata, Tomoyuki Momma, Zenichirou Saze & Shinji Ohki. (2017) Current status of cancer immunotherapy for esophageal squamous cell carcinoma. Esophagus 15:1, pages 1-9.
Crossref
Sonia Barberis, Mauricio Adaro, Anabella Origone, Grisel Bersi, Fanny Guzmán & Andrés Illanes. 2018. Biotechnological Applications of Plant Proteolytic Enzymes. Biotechnological Applications of Plant Proteolytic Enzymes 69 106 .
Hao Li, Nalini Schaduangrat, Saw Simeon & Chanin Nantasenamat. (2017) Computational study on the origin of the cancer immunotherapeutic potential of B and T cell epitope peptides. Molecular BioSystems 13:11, pages 2310-2322.
Crossref
Lin-Hai Yan, Zhi-Ning Chen, Li Li, Jia Chen, Xian-Wei Mo, Yu-Zhou Qin, Wen-E Wei, Hai-Quan Qin, Yuan Lin & Jian-Si Chen. (2016) E2F-1 promotes DAPK2-induced anti-tumor immunity of gastric cancer cells by targeting miR-34a. Tumor Biology 37:12, pages 15925-15936.
Crossref
Lanlan Liu, Huqiang Yi, Ce Wang, Huamei He, Ping Li, Hong Pan, Nan Sheng, Manyi Ji, Lintao Cai & Yifan Ma. (2016) Integrated Nanovaccine with MicroRNA-148a Inhibition Reprograms Tumor-Associated Dendritic Cells by Modulating miR-148a/DNMT1/SOCS1 Axis. The Journal of Immunology 197:4, pages 1231-1241.
Crossref
Michal Bassani-Sternberg & George Coukos. (2016) Mass spectrometry-based antigen discovery for cancer immunotherapy. Current Opinion in Immunology 41, pages 9-17.
Crossref
Yosuke Kano, Takahiro Iguchi, Hiroto Matsui, Keishi Adachi, Yukimi Sakoda, Tomoya Miyakawa, Shun Doi, Shoichi Hazama, Hiroaki Nagano, Yoshiya Ueyama & Koji Tamada. (2016) Combined adjuvants of poly(I:C) plus LAG ‐3‐Ig improve antitumor effects of tumor‐specific T cells, preventing their exhaustion . Cancer Science 107:4, pages 398-406.
Crossref
Junjie Xu & Wenwei Mao. (2016) Overview of Research and Development for Anticancer Drugs. Journal of Cancer Therapy 07:10, pages 762-772.
Crossref
Sailu Sarvagalla, Chun Hei Antonio Cheung, Ju-Ya Tsai, Hsing Pang Hsieh & Mohane Selvaraj Coumar. (2016) Disruption of protein–protein interactions: hot spot detection, structure-based virtual screening and in vitro testing for the anti-cancer drug target – survivin. RSC Advances 6:38, pages 31947-31959.
Crossref
Eran Ophir, Sara Bobisse, George Coukos, Alexandre Harari & Lana E. Kandalaft. (2016) Personalized approaches to active immunotherapy in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1865:1, pages 72-82.
Crossref
Koji Kono. 2016. Immunotherapy of Cancer. Immunotherapy of Cancer 135 142 .
Anand Rotte & Madhuri BhandaruAnand Rotte & Madhuri Bhandaru. 2016. Immunotherapy of Melanoma. Immunotherapy of Melanoma 351 416 .
NOBUHIRO TAKENO, AKIKO INUJIMA, KANNA SHINOHARA, MIYUKI YAMADA, NAOTOSHI SHIBAHARA, HIROAKI SAKURAI, IKUO SAIKI & KEIICHI KOIZUMI. (2015) Immune adjuvant effect of Juzentaihoto, a Japanese traditional herbal medicine, on tumor vaccine therapy in a mouse model. International Journal of Oncology 47:6, pages 2115-2122.
Crossref
Christina Pfirschke, Christoffer Gebhardt, Inka Zörnig, Maria Pritsch, Stefan B. Eichmüller, Dirk Jäger, Alexander Enk & Philipp Beckhove. (2015) T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response. Cancer Immunology, Immunotherapy 64:11, pages 1369-1381.
Crossref
L. Apetoh, S. Ladoire, G. Coukos & F. Ghiringhelli. (2015) Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?. Annals of Oncology 26:9, pages 1813-1823.
Crossref
Yun-Huan Zhen, Xiao-Hui Liu, Yuan Yang, Bo Li, Jing-Ling Tang, Qiang-Xing Zeng, Jie Hu, Xing-Nan Zeng, Lu Zhang, Ze-Jun Wang, Xiao-Yun Li, Hui-Xin Ge, Ola Winqvist, Ping-Sheng Hu & Jin Xiu. (2015) Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer. Cancer Immunology, Immunotherapy 64:9, pages 1083-1093.
Crossref
Jitka Fucikova, Irena Moserova, Linda Urbanova, Lucillia Bezu, Oliver Kepp, Isabelle Cremer, Cyril Salek, Pavel Strnad, Guido Kroemer, Lorenzo Galluzzi & Radek Spisek. (2015) Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in Immunology 6.
Crossref
Joseph Obeid, Yinin Hu & Craig L. SlingluffJrJr. (2015) Vaccines, Adjuvants, and Dendritic Cell Activators—Current Status and Future Challenges. Seminars in Oncology 42:4, pages 549-561.
Crossref
Mao Toyoda, Susumu Hama, Yutaka Ikeda, Yukio Nagasaki & Kentaro Kogure. (2015) Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis. International Journal of Pharmaceutics 483:1-2, pages 110-114.
Crossref
Charlotte N Maughan, Stephen G Preston & Gareth R Williams. (2015) Particulate inorganic adjuvants: recent developments and future outlook. Journal of Pharmacy and Pharmacology 67:3, pages 426-449.
Crossref
Meena Jhanwar-Uniyal, Michael Labagnara, Marissa Friedman, Amanda Kwasnicki & Raj Murali. (2015) Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets. Cancers 7:2, pages 538-555.
Crossref
Anand Rotte, Madhuri Bhandaru, Youwen Zhou & Kevin J. McElwee. (2015) Immunotherapy of melanoma: Present options and future promises. Cancer and Metastasis Reviews 34:1, pages 115-128.
Crossref
Dalal AlDeghaither, Brandon G. Smaglo & Louis M. Weiner. (2015) Beyond peptides and mAbs-current status and future perspectives for biotherapeutics with novel constructs. The Journal of Clinical Pharmacology 55:S3, pages S4-S20.
Crossref
Yu-Feng Xiao, Meng-Meng Jie, Bo-Sheng Li, Chang-Jiang Hu, Rui Xie, Bo Tang & Shi-Ming Yang. (2015) Peptide-Based Treatment: A Promising Cancer Therapy. Journal of Immunology Research 2015, pages 1-13.
Crossref
Zichao Luo, Ce Wang, Huqiang Yi, Ping Li, Hong Pan, Lanlan Liu, Lintao Cai & Yifan Ma. (2015) Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in?vivo. Biomaterials 38, pages 50-60.
Crossref
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou & Guido Kroemer. (2014) Classification of current anticancer immunotherapies. Oncotarget 5:24, pages 12472-12508.
Crossref
Stéphanie Corgnac, Rachel Perret, Lianjun Zhang, Jean-Pierre Mach, Pedro Romero & Alena Donda. (2014) iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine. Journal for ImmunoTherapy of Cancer 2:1.
Crossref
Pragya Srivastava, Benjamin E. Paluch, Junko Matsuzaki, Smitha R. James, Golda Collamat-Lai, Julia Karbach, Michael J. Nemeth, Pietro Taverna, Adam R. Karpf & Elizabeth A. Griffiths. (2014) Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts. Leukemia Research 38:11, pages 1332-1341.
Crossref
Joost PJJ Hegmans & Joachim GJV Aerts. (2014) Immunomodulation in cancer. Current Opinion in Pharmacology 17, pages 17-21.
Crossref
Øystein Bruserud, Tor Henrik Anderson Tvedt, Petter Quist Paulsen, Aymen Bushra Ahmed, Tobias Gedde-Dahl, Geir E. Tjønnfjord, Heidi Slåstad, Dag Heldal & Håkon Reikvam. (2014) Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies. Cancer Immunology, Immunotherapy 63:8, pages 757-777.
Crossref
Ngoc Kim Phan. (2014) Biological therapy: a new age of cancer treatment. Biomedical Research and Therapy 1:2.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.